CD4 and tuberculosis: Although the 2010 WHO ART guidelines are justified as a public health approach, it is important to study the TB treatment outcomes among the subgroup of HIV-infected TB patients with CD4 count of >350/mm3 and assess if they actually benefit by early initiation of ART.